DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 173 filers reported holding DIPLOMAT PHARMACY INC in Q4 2016. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $384,000 | -64.8% | 96,094 | -56.8% | 0.00% | -100.0% |
| Q3 2019 | $1,090,000 | -4.3% | 222,420 | +18.9% | 0.00% | 0.0% |
| Q2 2019 | $1,139,000 | +58.2% | 186,992 | +50.8% | 0.00% | 0.0% |
| Q1 2019 | $720,000 | -56.2% | 123,973 | +1.6% | 0.00% | -50.0% |
| Q4 2018 | $1,642,000 | -14.7% | 121,978 | +22.9% | 0.00% | 0.0% |
| Q3 2018 | $1,926,000 | -29.3% | 99,238 | -6.8% | 0.00% | -33.3% |
| Q2 2018 | $2,723,000 | +35.3% | 106,529 | +6.7% | 0.00% | +50.0% |
| Q1 2018 | $2,012,000 | +4.8% | 99,834 | +4.3% | 0.00% | 0.0% |
| Q4 2017 | $1,920,000 | -12.7% | 95,684 | -9.9% | 0.00% | 0.0% |
| Q3 2017 | $2,199,000 | +91.7% | 106,176 | +37.1% | 0.00% | +100.0% |
| Q2 2017 | $1,147,000 | +28.6% | 77,472 | +38.6% | 0.00% | 0.0% |
| Q1 2017 | $892,000 | +171.1% | 55,899 | +114.3% | 0.00% | – |
| Q4 2016 | $329,000 | -86.8% | 26,080 | -70.8% | 0.00% | -100.0% |
| Q3 2016 | $2,498,000 | -24.8% | 89,196 | -6.0% | 0.00% | -20.0% |
| Q2 2016 | $3,322,000 | +22.5% | 94,910 | -4.1% | 0.01% | +25.0% |
| Q1 2016 | $2,711,000 | +75.8% | 98,957 | +119.5% | 0.00% | +33.3% |
| Q4 2015 | $1,542,000 | +160.5% | 45,075 | +118.8% | 0.00% | +200.0% |
| Q3 2015 | $592,000 | +13.6% | 20,598 | +77.0% | 0.00% | 0.0% |
| Q2 2015 | $521,000 | – | 11,638 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|